OMOP Concept 44036717

Octinoxate 0.0105 MG/ML / octocrylene 0.03 MG/ML / titanium dioxide 0.0125 MG/ML Topical Suspension [Daytime Fluid] by Intega Skin

StandardDrugRxNorm ExtensionOMOP1031348Marketed Product
Maps from
1
Descendants
0
Valid from
24 Aug 2017
Valid to
31 Dec 2099
OMOP concepts

Concept Lookup Tool

Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.

Source codes that map to this concept

1 source code normalizes to Octinoxate 0.0105 MG/ML / octocrylene 0.03 MG/ML / titanium dioxide 0.0125 MG/ML Topical Suspension [Daytime Fluid] by Intega Skin via the OMOP "Maps to" relationship.

VocabularyCodeNameType
DPD2437015Daytime Fluid [Drug]Non-standard

Where it sits in the hierarchy

Ordered by distance - 1 is a direct parent or child.

Get this concept via the API

Resolve Octinoxate 0.0105 MG/ML / octocrylene 0.03 MG/ML / titanium dioxide 0.0125 MG/ML Topical Suspension [Daytime Fluid] by Intega Skin - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.

curl "https://api.omophub.com/v1/concepts/44036717?include_relationships=true" \
  -H "Authorization: Bearer $OMOPHUB_API_KEY"
Get your free API key3,000 calls/month free · no credit card